Navigation Links
Cellular Dynamics International's (CDI) Human Induced Pluripotent Stem Cell (iPSC) Technology Named the Gold Winner in The Wall Street Journal 2011 Technology Innovation Awards
Date:10/17/2011

MADISON, Wis., Oct. 17, 2011 /PRNewswire/ -- Cellular Dynamics International (CDI) today announced that it was named as the overall Gold winner in The Wall Street Journal Technology Innovation Awards.

The Wall Street Journal 2011 Technology Innovation Awards are determined by a panel of independent judges who evaluated significant innovations that occurred in 2010.  Six-hundred-five applicants competed for the award in 16 categories.  Of these, the panel chose 35 winners and runners-up.

"Medical research has been challenged by the lack of access to a consistent supply of human cells, such as heart or brain cells," said Dr. James Thomson, CDI founder and chief scientific officer.  "Research today employs proxies, such as animal cells, tumor cell lines or cadaveric tissue, none of which truly reflect human biology.  I founded CDI based on my desire to make pluripotent stem cells and human tissue cells widely available to accelerate discoveries in human health and biological research. CDI's production technology and capacity provide this access, enabling us to manufacture human material from anyone. CDI has overcome the scalability challenges, mass producing industrial quantities of human cells in high quality and purity."

CDI has developed a proprietary manufacturing process in which cells isolated from a doctor's office standard blood draw from virtually anyone can be reprogrammed into that individual's personal pluripotent stem cell line.  CDI can then differentiate these stem cells into any cell type in the human body in industrial quantity, quality and purity so that scientists have a consistent supply of human cells from specific individuals.  Two human cell products, iCell® Cardiomyocytes (heart muscle cells) and iCell Endothelial Cells (blood vessel cells), have been launched over the past two years, with neurons and liver cells already available in early access collaborations with researchers worldwide.

"CDI is the first company to utilize stem cell technology to manufacture the vast quantities of high quality stem cells and tissue cells required to better understand human biology, revolutionize the drug discovery process, and develop cell-based therapies to treat human diseases," said Robert Palay, chairman of the board and CDI chief executive officer.  "We are honored that The Wall Street Journal's panel of independent judges recognized our company as a breakthrough innovator in human medicine and biotechnology."

About Cellular Dynamics International, Inc.

Cellular Dynamics International, Inc. (CDI) is a leading developer of next-generation stem cell technologies for drug development, cell therapy, tissue engineering and organ regeneration.  CDI harnesses its unique manufacturing technology to produce differentiated tissue cells from any individual's stem cell line in industrial quality, quantity and purity. CDI is accelerating the adoption of pluripotent stem cell technology, adapting its methods to fit into standard clinical practice by the creation of individual stem cell lines from a standard blood draw.  CDI was founded in 2004 by Dr. James Thomson, a pioneer in human pluripotent stem cell research at the University of Wisconsin-Madison.  CDI's facilities are located in Madison, Wisconsin. See www.cellulardynamics.com.


'/>"/>
SOURCE Cellular Dynamics International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Profiler at the cellular level
2. Cellular Dynamics Launches Innovative Research Grant Program
3. Permeon reveals discovery of Intraphilins as new approach to intracellular biologic drugs
4. Medical College of Wisconsin and Cellular Dynamics Awarded NHLBI Grant Using Human Induced Pluripotent Stem Cells
5. Arteriocyte and the U.S. Army Institute of Surgical Research (USAISR) Sign a CRADA to Speed Development of Cellular Therapies for Orthopaedic Trauma
6. Terumo Americas Holding, Inc., Agrees to Acquire Harvest Technologies Corporation, a Leader in the Development of Point-of-Care Cellular Therapy
7. Cellular Dynamics Licenses Technology From ViaCyte
8. Cellular Dynamics International Scientists Report on Efficient Method to Produce Footprint-Free Induced Pluripotent Stem Cells (iPSCs) Under Feeder-Free Conditions
9. Summer Street Research Partners Closes Financing for ImmunoCellular Therapeutics, Ltd.
10. Cellular Dynamics International to Present at 29th Annual JPMorgan Healthcare Conference
11. Intra-Cellular Therapies Announces Positive Results with ITI-002 in Pre-Clinical Models of Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Jan. 18, 2017  Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ... immune therapies for operable and inoperable solid tumor cancers, ... Technical Officer of NW Bio, will present at the ... at the Hyatt Regency Hotel in Miami, ... the session entitled "New Therapeutic Approaches – Expanding the ...
(Date:1/18/2017)... , Jan. 18, 2017   Boston Biomedical , ... designed to target cancer stemness pathways, will feature data ... napabucasin, at the 2017 ASCO Gastrointestinal Cancers Symposium, held ... . Napabucasin is an orally-administered investigational ... STAT3. i Cancer stem cells (CSCs) possess the ...
(Date:1/18/2017)... Whitehouse, NJ (PRWEB) , ... January 18, 2017 ... ... access to more and more E&L expertise. Within Albany Molecular Research, Inc. (AMRI), ... doubled in the past year and is planned for further growth in 2017. ...
(Date:1/18/2017)... ... January 18, 2017 , ... BidMed, LLC, ... research and genetic testing lab equipment from two different leading institutes. This highly specialized ... regions of the United States. This 1-day online auction will take place on ...
Breaking Biology Technology:
(Date:1/19/2017)... CLARA, Calif. , Jan. 19, 2017 /PRNewswire/ ... company enhancing user experience and security for consumer ... of next-generation payment processing systems and cybersecurity solutions, ... more banks, enterprises and financial institutions worldwide to ... part of the end-to-end secure user authentication platforms ...
(Date:1/13/2017)... WASHINGTON, N.Y. , Jan. 13, 2017 /PRNewswire/ ... of technology solutions for the homecare industry, including ... of homecare industry expert, Justin Jugs, as Senior ... brings more than 15 years of homecare experience ... team in developing strategic plans to align Sandata,s ...
(Date:1/12/2017)... , January 12, 2017 A new report by Allied Market ... the global biometric technology market is expected to generate revenue of $10.72 billion by ... Continue Reading ... Allied Market Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20140911/647229) ...
Breaking Biology News(10 mins):